CBD Nutraceuticals Market Set For Explosive Growth, Projected To Reach $29.1B By 2030

The global cannabidiol (CBD) nutraceuticals sector is on track for substantial expansion. Recent projections from Research and Markets indicate that the market could be valued at $29.1 billion by 2030. This forecast reflects significant growth from the market’s current valuation of $9.7 billion in 2024.

The growth drivers highlighted by the report include increasing consumer demand for plant-based foods, rising awareness about the health benefits of CBD nutraceuticals and the introduction of innovative products. Additionally, the development of capsule and softgel forms of CBD is expected to push the market forward, with ongoing advancements making these formats even more accessible.

North America Leads The Charge

North America continues to dominate the global market for CBD nutraceuticals, spurred by the 2018 Farm Bill that legalized hemp cultivation and the processing of hemp-derived products in U.S. A combination of consumer demand for the benefits of CBD, strong participation from major companies and an aging population has solidified North America as the primary market driver.

Asia Pacific Poised For Fastest Growth

While North America leads the CBD nutraceutical space, Asia-Pacific is anticipated to see the fastest growth during the forecast period. Key factors include the entry of leading global players into the region, a rising number of lifestyle-related health issues and greater awareness of healthier eating habits.

Oils And Isolates: Market Subsector Trends

Among the various CBD nutraceutical formats, CBD oils currently account for the largest market share due to their versatility across applications like capsules, tinctures and cosmetics. However, CBD isolates are expected to experience the fastest growth, driven by their high purity and suitability for formulations requiring precise CBD concentrations.

CBD tinctures remain in high demand for their application in treating a wide range of health conditions, including insomnia, cancer cell growth, seizures and chronic pain. However, the report notes that CBD capsules and softgels are projected to grow at the fastest pace through 2030 due to their convenience and travel-friendly nature.

Cover image made with AI